Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$12.73 USD
+0.29 (2.33%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $12.71 -0.02 (-0.16%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
- YR Estimate
- 06/30/2023
- 06/30/2022
- 06/30/2021
- 06/30/2020
- 06/30/2019
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health
- 659.90
- 607.06
- 545.72
- 526.90
- 531.97
- Revenue - Line of Business (LOBR)
- Net Sales: Mineral Nutrition
- 242.70
- 259.51
- 220.56
- 214.41
- 233.78
- Revenue - Line of Business (LOBR)
- Net Sales: Performance Products
- 75.40
- 75.69
- 67.07
- 59.04
- 62.24
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health: MFAs and other
- 387.30
- 361.54
- 330.02
- 322.30
- 350.47
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health: Nutritional Specialties
- 172.50
- 157.20
- 142.76
- 129.26
- 113.22
- Revenue - Line of Business (LOBR)
- Net Sales: Animal Health: Vaccines
- 100.00
- 88.32
- 72.94
- 75.34
- 68.29
- Revenue - Geographic (GEOR)
- Net Sales by Region: United States
- 578.77
- 561.80
- 494.89
- 471.94
- 480.10
- Revenue - Geographic (GEOR)
- Net Sales by Region: Latin America and Canada
- 219.85
- 191.05
- 166.33
- 158.94
- 152.38
- Revenue - Geographic (GEOR)
- Net Sales by Region: Europe, Middle East and Africa
- 117.82
- 122.48
- 114.13
- 112.18
- 105.37
- Revenue - Geographic (GEOR)
- Net Sales by Region: Asia Pacific
- 61.46
- 66.93
- 58.01
- 57.30
- 90.15
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Animal Health
- 136.14
- 124.11
- 123.95
- 123.11
- 136.05
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Mineral Nutrition
- 17.42
- 24.04
- 17.12
- 14.68
- 15.71
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Performance Products
- 9.35
- 8.71
- 9.44
- 4.53
- 4.73
- Income - Line of Business (LOBI)
- Adjusted EBITDA: Corporate
- -50.15
- -45.77
- -42.62
- -40.18
- -38.45